Spotlight
Clinical
CME
Partners
FDA approves new labeling claims for Tecnis IOL
Pfizer Inc. announces that the FDA has approved new labeling claims forits Tecnis IOL. The approval marks the first time a lens has received suchclaims for reduction of postoperative spherical abberations and improvednight-driving simulator performance, the company said in a prepared statement.
Related Videos
Related Content
